Zalicus Inc Com (NASDAQ:ZLCS)

CAPS Rating: 4 out of 5

A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 10/3/2012 3:40:25 PM : Outperform Start Price: $0.70 ZLCS Score: -12.58

It has been Dumping, so you might want to green flag it now before the Pumping begins

Featured Broker Partners


Advertisement